Literature DB >> 9221300

[Drug therapy of tachycardic atrial arrhythmias].

D Wietholt1, H Gülker.   

Abstract

There are defined indications for the acute pharmacological management of AV-nodal reentry tachycardias, AV reentry tachycardias and for the acute and chronic ventricular rate control in atrial fibrillation. Possible indications arise for the chronic pharmacologic therapy of AV reentry tachycardias, pharmacological cardioversion and prophylaxis of atrial fibrillation. In future there will be a trend towards nonpharmacological management of atrial arrhythmias.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9221300     DOI： 10.1007/bf03043257

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


  11 in total

1.  The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation.

Authors:  F I Marcus
Journal:  Am J Cardiol       Date:  1990-08-01       Impact factor: 2.778

Review 2.  [Nonrheumatic atrial fibrillation. Rhythm conversion or anticoagulation?].

Authors:  W Lengfelder; J Senges
Journal:  Dtsch Med Wochenschr       Date:  1992-03-27       Impact factor: 0.628

Review 3.  [The therapy of atrial fibrillation. Rhythm or rate control?].

Authors:  J Carlsson; S Miketić; R Meierhenrich; U Tebbe
Journal:  Dtsch Med Wochenschr       Date:  1997-01-24       Impact factor: 0.628

Review 4.  Proarrhythmia in patients treated for atrial fibrillation or flutter.

Authors:  R H Falk
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

5.  Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.

Authors:  J P DiMarco; T D Sellers; R M Berne; G A West; L Belardinelli
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

6.  Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium.

Authors:  M A Brodsky; B J Allen; C J Walker; T P Casey; C R Luckett; W L Henry
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

7.  Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.

Authors:  R V Lewis; N Irvine; D G McDevitt
Journal:  Eur Heart J       Date:  1988-07       Impact factor: 29.983

8.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

9.  Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.

Authors:  E M Antman; A D Beamer; C Cantillon; N McGowan; P L Friedman
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

10.  Differential diagnosis of tachycardia with narrow QRS complex (shorter than 0.12 second).

Authors:  F W Bär; P Brugada; W R Dassen; H J Wellens
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.